ScholarIQanswers from OpenAlex & ORCID
Kelley R. Branch
ResearcherPublications, citations & collaboration network
Kelley R. Branch is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kelley R. Branch have?
ScholarIQindexed works
Kelley R. Branch has 190 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kelley R. Branch have?
ScholarIQcitation count
Kelley R. Branch has 16,978 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kelley R. Branch?
ScholarIQh-index
Kelley R. Branch has an h-index of 44 in OpenAlex.
What is the i10-index of Kelley R. Branch?
ScholarIQi10-index
Kelley R. Branch has an i10-index of 85 in OpenAlex.
What is the ORCID of Kelley R. Branch?
ScholarIQorcid
The ORCID for Kelley R. Branch is on the source record.
What is the OpenAlex record for Kelley R. Branch?
ScholarIQopenalex
The OpenAlex for Kelley R. Branch is on the source record.
What are the most-cited papers on Kelley R. Branch?
ScholarIQmost cited works
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W. Eikelboom, Stuart J. Connolly, Jackie Bosch, Gilles R. Dagenais, Robert G. Hart, Olga Shestakovska, Rafael Díaz, Marco Alings, Eva Lonn, Sonia S. Anand, Petr Widimský, Masatsugu Hori, Álvaro Avezum, Leopoldo Soares Piegas, Kelley R. Branch, Jeffrey L. Probstfield, Deepak L. Bhatt, Jun Zhu, Yan Liang, Aldo P. Maggioni, Patricio López‐Jaramillo, Martin O’Donnell, Ajay K. Kakkar, Keith A.A. Fox, Alexander Parkhomenko, Georg Ertl, Stefan Störk, Mátyás Keltai, Lars Rydén, Nana Pogosova, Antonio L Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek J. Guzik, Peter Verhamme, Dragoş Vinereanu, Jae‐Hyung Kim, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Philippe Gabríel Steg, Kaj Metsärinne, Nancy Cook Bruns, Frank Misselwitz, Edmond Chen, Darryl P. Leong, Salim Yusuf
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Naveed Sattar, Matthew M.Y. Lee, Søren Lund Kristensen, Kelley R. Branch, Stefano Del Prato, Nardev S. Khurmi, Carolyn S.P. Lam, Renato D. Lópes, John J.V. McMurray, Richard E. Pratley, Julio Rosenstock, Hertzel C. Gerstein
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Sonia S. Anand, Jackie Bosch, John W. Eikelboom, Stuart J. Connolly, Rafael Díaz, Peter Widimsky, Victor Aboyans, Marco Alings, Ajay K. Kakkar, Katalin Keltai, Aldo P. Maggioni, Basil S. Lewis, Stefan Störk, Jun Zhu, Patricio López‐Jaramillo, Martin O’Donnell, Patrick Commerford, Dragoş Vinereanu, Nana Pogosova, Lars Rydén, Keith A.A. Fox, Deepak L. Bhatt, Frank Misselwitz, George Varigos, Thomas Vanassche, Álvaro Avezum, Edmond Chen, Kelley R. Branch, Darryl P. Leong, Shrikant I. Bangdiwala, Robert G. Hart, Salim Yusuf, JORGELINA SALA, Luis R Cartasegna, MARISA VICO, Miguel Hominal, Eduardo Hasbani, Alberto Caccavo, Cesar Javier Zaidman, DANIEL VOGEL, Adrian D. Hrabar, Pablo Schygiel, Carlos Alberto Cuneo, Hugo A Luquez, Ignacio MacKinnon, Rodolfo Andrés Ahuad Guerrero, Juan Pablo Costabel, INES PALMIRA BARTOLACCI, Oscar Montaña, María Antonietta Barbieri, Oscar Gómez Vilamajó, RUBEN OMAR GARCIA DURAN, Lilia Beatriz Schiavi, Marcelo Garrido, ADRIAN INGARAMO, Anselmo P. Bordonava, MARIA JOSE PELAGAGGE, LEONARDO NOVARETTO, JUAN PABLO ALBISU DI GENNERO, LUZ MARIA IBANEZ SAGGIA, MOIRA ALVAREZ, Néstor A. Vita, Stella M. Macı́n, Ricardo D. Dran, Marcelo Cardona, Luis Guzman, RODOLFO JUAN SARJANOVICH, Jesus Cuadrado, SEBASTIAN NANI, MARCOS RAUL LITVAK BRUNO, Carolina Chacón, Laura Maffei, Diego Grinfeld, NATALIA VENSENTINI, CLAUDIO RODOLFO MAJUL, Héctor Luciardi, PATRICIA DEL CARMEN GONZALEZ COLASO, FREDY ANTONI FERRE PACORA, PAUL VAN DEN HEUVEL, Peter Verhamme, Bavo Ector, PHILIPPE DEBONNAIRE, Philippe van de Borne, JEAN LEROY, Herman Schroë, Pascal Vranckx, Ivan Elegeert, E Hoffer, KARL DUJARDIN, CLARISSE INDIO DO BRASIL, Dalton Bertolim Précoma, JOSE ANTONIO ABRANTES, Euler Roberto Fernandes Manenti, Gilmar Reis, José Francisco Kerr Saraiva, Lília Nigro Maia, Mauro Esteves Hernandes, Paulo Roberto Ferreira ROSSI, Fabio Rossi dos Santos, Sérgio Luiz Zimmermann
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
Stuart J. Connolly, John W. Eikelboom, Jackie Bosch, Gilles R. Dagenais, Leanne Dyal, Fernando Laņas, Kaj Metsärinne, Martin O’Donnell, Anthony L Dans, Jong‐Won Ha, Alexander Parkhomenko, Álvaro Avezum, Eva Lonn, Liu Lisheng, Christian Torp‐Pedersen, Petr Widimský, Aldo P. Maggioni, Camilo Félix, Katalin Keltai, Masatsugu Hori, Khalid Yusoff, Tomasz J. Guzik, Deepak L. Bhatt, Kelley R. Branch, Nancy Cook Bruns, Scott D. Berkowitz, Sonia S. Anand, George Varigos, Keith A.A. Fox, Salim Yusuf, JORGELINA SALA, Luis R Cartasegna, MARISA VICO, Miguel Hominal, Eduardo Hasbani, Alberto Caccavo, Cesar Javier Zaidman, DANIEL VOGEL, Adrian D. Hrabar, Pablo Schygiel, Carlos Alberto Cuneo, Hugo A Luquez, Ignacio MacKinnon, Rodolfo Andrés Ahuad Guerrero, Juan Pablo Costabel, INES PALMIRA BARTOLACCI, Oscar Montaña, María Antonietta Barbieri, Oscar Gómez Vilamajó, RUBEN OMAR GARCIA DURAN, Lilia Beatriz Schiavi, Marcelo Garrido, ADRIAN INGARAMO, Anselmo P. Bordonava, MARIA JOSE PELAGAGGE, LEONARDO NOVARETTO, JUAN PABLO ALBISU DI GENNERO, LUZ MARIA IBANEZ SAGGIA, MOIRA ALVAREZ, Néstor A. Vita, Stella M. Macı́n, Ricardo D. Dran, Marcelo Cardona, Luis Guzman, RODOLFO JUAN SARJANOVICH, Jesus Cuadrado, SEBASTIAN NANI, MARCOS RAUL LITVAK BRUNO, Carolina Chacón, Laura Maffei, Diego Grinfeld, NATALIA VENSENTINI, CLAUDIO RODOLFO MAJUL, Héctor Luciardi, PATRICIA DEL CARMEN GONZALEZ COLASO, FREDY ANTONI FERRE PACORA, PAUL VAN DEN HEUVEL, Peter Verhamme, Bavo Ector, PHILIPPE DEBONNAIRE, Philippe van de Borne, JEAN LEROY, Herman Schroë, Pascal Vranckx, Ivan Elegeert, E Hoffer, KARL DUJARDIN, CLARISSE INDIO DO BRASIL, Dalton Bertolim Précoma, JOSE ANTONIO ABRANTES, Euler Roberto Fernandes Manenti, Gilmar Reis, José Francisco Kerr Saraiva, Lília Nigro Maia, Mauro Esteves Hernandes, Paulo Roberto Ferreira ROSSI, Fabio Rossi dos Santos, Sérgio Luiz Zimmermann, RAFAEL RECH, EDUARDO ABIB
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Paul Moayyedi, John W. Eikelboom, Jackie Bosch, Stuart J. Connolly, Leanne Dyal, Olga Shestakovska, Darryl P. Leong, Sonia S. Anand, Stefan Störk, Kelley R. Branch, Deepak L. Bhatt, Peter Verhamme, Martin O’Donnell, Aldo P. Maggioni, Eva Lonn, Leopoldo Soares Piegas, Georg Ertl, Mátyás Keltai, Nancy Cook Bruns, Eva Muehlhofer, Gilles R. Dagenais, Jae‐Hyung Kim, Masatsugu Hori, Philippe Gabríel Steg, Robert G. Hart, Rafael Díaz, Marco Alings, Petr Widimský, Álvaro Avezum, Jeffrey L. Probstfield, Jun Zhu, Yan Liang, Patricio López‐Jaramillo, Ajay K. Kakkar, Alexander Parkhomenko, Lars Rydén, Nana Pogosova, Antonio L Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek J. Guzik, Dragoş Vinereanu, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Kaj Metsärinne, Keith A.A. Fox, Salim Yusuf